Rivastigmine

Rivastigmine for the Treatment of Hypoactive Anticholinergic Delirium and CNS Depression Associated Mainly With Clozapine Poisoning.

Rivastigmine to Prevent Recurrence of Antimuscarinic Delirium

Rivastigmine for Antimuscarinic Delirium

A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.

Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy

Open Label Trial of Rivastigmine Patch in Subjects With Mild to Moderate Stage AD Having Coexisting svCVD

Noradrenaline, Acetylcholine and Dynamic Learning in Healthy Humans

Cholinesterase Inhibitors to Slow Progression of Visual Hallucinations in Parkinson&Apos;s Disease

Methylphenidate, Rivastigmine or Haloperidol in Hypoactive Delirium in Intensive Care Patients

Pharmacovigilance in Gerontopsychiatric Patients

A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy

Rivastigmine Capsules in Patients With Probable Vascular Dementia

Comparative Research of Alzheimer's Disease Drugs

Rivastigmine For Methamphetamine Dependent Individuals

Brain Changes by Rivastigmine According to Butyrylcholinesterase Alleles

Rivastigmine Study in Adolescents With Down Syndrome

Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study

A Double-Blind, Placebo-controlled Crossover Study of Repeat Rivastigmine Administration in Healthy Male Volunteers

Efficacy of Rivastigmine in Patients With Down Syndrome

Rivastigmine as a Treatment for Methamphetamine Dependence